“Lower drug prices, patent expiries of blockbuster drugs and Government support to boost local production will thrive the Generics market”, says RNCOS.
Noida, UP -- (SBWIRE) -- 01/20/2015 -- According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", the Brazil pharmaceutical industry has been witnessing higher growth in Generics drug production owing to Government support and patent expiries of various blockbuster drugs. In 2013, Generic drugs accounted for 26% of the pharmaceutical market in Brazil, generating approximately US$ 7.0 Billion revenue. With a price at least 35% cheaper than brand?name drugs and several Brazilian companies operating in the sector, generic manufacturing has been identified as an ideal way to increase budget control and boost local manufacturing.
The higher production of these drugs has been the result of the rising number of laboratories engaged in research and development. In 2013, about 90% of these drugs were locally produced and only 10% were imported. Domestic Companies such as EMS Pharma, Ache, Hypermarcas, and Eurofarma surpass foreign players in generics drug sales. EMS Pharma has been the leader in generic industry with the highest number of drugs registered, followed by Medley (now, a part of Sanofi), Eurofarma, and Neo Quimica (now, a part of Hypermarcas).
The report is spread in over 85 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Brazilian Pharmaceutical industry. The study presents a transparent picture about different pharma segments such as Generics, OTC and Prescription Drugs including the factors affecting their growth. The research further covers Pharmaceutical Production, Therapeutic Segments, Growth Drivers and Challenges as well as Mergers and Acquisitions. The report also covers detailed information about active market players in the Brazil pharmaceutical industry, including domestic and foreign players to enable the clients to understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the Brazilian Pharmaceutical market, providing an in-depth research and prudent analysis of the key segments.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM726.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.